ArticleFrontiers in immunology2026

Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy.

Miao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.